Author: Nathan Drapkin
The US drug‑pricing environment is shifting rapidly — and this time, the changes aren't temporary. States, federal agencies and the courts are all driving reforms that affect pharmacy costs, benefit design and contract strategy. Employers will face more variability, more oversight and more pressure to make informed decisions quickly.
For employers, this shift means:
- More cost volatility
- More state‑specific rules
- More scrutiny on pharmacy benefit managers (PBMs)
- Less predictability
- Greater urgency to adapt quickly
This whitepaper summarizes the major forces shaping 2026 and provides practical, employer-focused guidance on how to navigate this environment. Talk to a Gallagher Pharmacy and Health Plan Services consultant or visit ajg.com/pharmacy to learn more.
